Arvinas (ARVN) Short-term Investments (2017 - 2026)

Arvinas (ARVN) recorded quarterly Short-term Investments of $527.6 million in Q1 2026, down 2.75% quarter-over-quarter from $542.5 million in Q4 2025, and down 39.59% on a YoY basis from $873.3 million in Q1 2025.

Arvinas (ARVN) Short-term Investments (2017 - 2026) Analysis & Trends

Arvinas' Short-term Investments history runs 10 years deep, the most recent figure standing at $527.6 million for Q1 2026.

  • In Q1 2026, Short-term Investments fell 39.59% year-over-year to $527.6 million; the TTM figure through Mar 2026 stood at $527.6 million (down 39.59% YoY), while the FY2025 annual figure was $542.5 million, down 42.22% from the prior year.
  • Short-term Investments was $527.6 million for Q1 2026 at Arvinas, down from $542.5 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $1.1 billion in Q2 2024 to a low of $4.5 million in Q1 2022.
  • Historically, Short-term Investments has averaged $436.3 million across 5 years, with a median of $527.6 million in 2026.
  • The sharpest annual moves came in 2022 and 2024: Short-term Investments plunged 99.18% in 2022, then jumped 19425.45% in 2024.
  • A 5-year view of Short-term Investments shows it stood at $5.5 million in 2022, then surged by 17160.0% to $949.3 million in 2023, then slipped by 1.1% to $938.9 million in 2024, then slumped by 42.22% to $542.5 million in 2025, then retreated by 2.75% to $527.6 million in 2026.
  • The last three Short-term Investments figures came in at $527.6 million (Q1 2026), $542.5 million (Q4 2025), and $686.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Arvinas 492.16 Mn -122.74 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 527.60 Mn
Dec 31, 2025 542.50 Mn
Sep 30, 2025 686.10 Mn
Jun 30, 2025 746.30 Mn
Mar 31, 2025 873.30 Mn
Dec 31, 2024 938.90 Mn
Sep 30, 2024 1.04 Bn
Jun 30, 2024 1.07 Bn
Mar 31, 2024 5.50 Mn
Dec 31, 2023 949.30 Mn
Sep 30, 2023 5.50 Mn
Jun 30, 2023 5.50 Mn
Mar 31, 2023 5.50 Mn
Dec 31, 2022 5.50 Mn
Sep 30, 2022 5.50 Mn
Jun 30, 2022 4.50 Mn
Mar 31, 2022 4.50 Mn
Dec 31, 2021 4.50 Mn
Sep 30, 2021 4.50 Mn
Jun 30, 2021 551.85 Mn